Bill
Bill > H1281
FL H1281
FL H1281Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs
summary
Introduced
01/08/2026
01/08/2026
In Committee
01/15/2026
01/15/2026
Crossed Over
Passed
Dead
03/13/2026
03/13/2026
Introduced Session
2026 Regular Session
Bill Summary
An act relating to prohibitions against discriminatory practices relating to 340B entities and 340B drugs; providing a short title; creating s. 499.061, F.S.; providing definitions; prohibiting drug manufacturers from engaging in certain acts against the acquisitions of 340B drugs by and the delivery of such drugs to specified pharmacies; providing an exception; prohibiting drug manufacturers from interfering with pharmacies' rights to contract with 340B entities; providing that each commission of certain acts constitutes a violation of the Florida Deceptive and Unfair Trade Practices Act and subjects the violator to certain actions and penalties; providing construction and applicability; creating s. 626.8829, F.S.; providing definitions; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; providing applicability; providing that each commission of certain acts constitutes a violation of the Florida Deceptive and Unfair Trade Practices Act and subjects the violator to certain actions and penalties; providing construction; creating ss. 627.64743, 627.65733, and 641.31543, F.S.; providing definitions; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of these insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; providing applicability; providing that each commission of certain acts constitutes a violation of the Florida Deceptive and Unfair Trade Practices Act and subjects the violator to certain actions and penalties; providing construction; providing an effective date.
AI Summary
This bill, titled the "Defending Affordable Prescription Drug Costs Act," aims to prevent discriminatory practices against entities and drugs within the 340B Drug Pricing Program, a federal program that provides reduced prices on outpatient drugs to eligible healthcare organizations. Specifically, it prohibits drug manufacturers from interfering with the acquisition or delivery of 340B drugs to pharmacies contracted with 340B entities, and also prevents them from obstructing these pharmacies' ability to contract with 340B entities. Furthermore, the bill prohibits health insurance issuers, pharmacy benefit managers (PBMs), and other third-party payors from engaging in discriminatory reimbursement practices for 340B drugs, such as paying lower rates than for non-340B drugs, imposing different terms or conditions, or creating barriers for patients choosing to receive these drugs from 340B entities or their contracted pharmacies. These actions are considered violations of the Florida Deceptive and Unfair Trade Practices Act, carrying potential penalties. The bill includes exceptions for limited drug distribution under specific federal risk management strategies and clarifies that it does not conflict with federal law.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Died in Health Care Facilities & Systems Subcommittee (on 03/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.flsenate.gov/Session/Bill/2026/1281 |
| BillText | https://www.flsenate.gov/Session/Bill/2026/1281/BillText/Filed/PDF |
Loading...